trending Market Intelligence /marketintelligence/en/news-insights/trending/zewm-a-ctly1ysvelohrqg2 content esgSubNav
In This List

Sinovac Biotech extends termination date of going-private deal

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Sinovac Biotech extends termination date of going-private deal

Sinovac Biotech Ltd. extended the termination date of its going-private deal to April 26.

The original termination date was March 26.

The Beijing-based biopharmaceutical company agreed to go private in a $400 million transaction in June 2017. The transaction initially was expected to close in the second half of 2017.